Welcome to the Peptide Therapeutics Foundation

The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: Ferring Pharmaceuticals, Neurocrine Biosciences Inc., Novo Nordisk, the PolyPeptide Group, Takeda Pharmaceuticals and Zealand Pharma. To learn more about our corporate sponsors and board members click here.

Click here for an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
“Peptide Therapeutics Update.”  M.K. Dunn, Ferring Research Institute, Inc.
Citation: Presented at the 13th Annual Peptide Therapeutics Symposium, La Jolla, California, October 2018.